Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S6OH
|
|||
| Former ID |
DIB003206
|
|||
| Drug Name |
Relaxin
|
|||
| Synonyms |
Relaxin (once-weekly, heart failure)
Click to Show/Hide
|
|||
| Indication | Cardiac failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9] | Phase 3 | [1], [2] | |
| Company |
Ambrx Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1994). | |||
| REF 2 | ClinicalTrials.gov (NCT00704665) Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.